nasopharyng
carcinoma
npc
rare
popul
around
world
common
china
southeast
asia
incid
reach
per
individu
epsteinbarr
viru
ebv
consid
major
risk
factor
npc
doserespons
relationship
ebv
antibodi
npc
risk
ebv
present
world
popul
often
form
vivo
latenc
healthi
carrier
low
copi
episom
viru
maintain
rest
memori
b
cell
dcsign
dendrit
cellspecif
intercellular
adhes
molecul
grab
nonintegrin
encod
chromosom
ctype
lectin
express
subset
dendrit
cell
dc
alveolar
macrophag
function
cell
adhes
receptor
pathogen
recognit
receptor
act
pathogen
uptak
receptor
dcsign
could
mediat
interact
plethora
pathogen
includ
bacteria
helicobact
pylori
virus
ebola
cytomegaloviru
hepatitisc
viru
dengu
viru
sarscov
parasit
leishmania
pifanoi
sever
studi
recent
report
role
dcsign
promot
variant
suscept
pathogenesi
variou
infecti
diseas
dengu
fever
tuberculosi
acquir
immun
defici
syndrom
aid
celiac
diseas
sakuntabhai
et
al
report
g
allel
variant
dcsign
associ
strong
protect
dengu
fever
addit
sever
previou
report
suggest
variant
dcsign
promot
confer
protect
tuberculosi
howev
whether
dcsign
promot
variant
effect
suscept
npc
still
unknown
far
studi
report
variant
dcsign
promot
cantones
popul
therefor
explor
relationship
dcsign
promot
polymorph
suscept
npc
determin
dcsign
promot
sequenc
variat
casecontrol
studi
cantones
subject
unrel
cantones
popul
guangdong
provinc
china
case
recruit
consecut
decemb
octob
patholog
confirm
diagnosi
npc
sun
yatsen
univers
cancer
center
sysucc
guangzhou
china
total
npc
patient
collect
cantones
origin
live
southern
china
popul
control
cancerfre
individu
randomli
select
individu
attend
annual
communitybas
physic
examin
time
period
select
criteria
control
subject
includ
individu
histori
cancer
cantones
match
npc
case
age
year
sex
time
period
blood
sampl
collect
total
control
involv
studi
subject
sign
inform
consent
agreement
epidemiolog
data
blood
sampl
collect
train
sysucc
staff
interview
case
control
venou
blood
specimen
total
ml
collect
subject
genom
dna
extract
lymphocyt
use
qiaamp
dna
blood
midi
kit
qiagen
german
follow
manufactur
protocol
procedur
review
approv
human
ethic
approv
committe
sysucc
region
approxim
bp
upstream
atg
start
codon
includ
promot
region
amplifi
use
follow
primer
gcagtcttggttccttggag
forward
primer
acttgcagtgcctcctcagt
revers
primer
forward
primer
revers
primer
primer
delimit
promot
region
nt
genbank
amplifi
bp
fragment
primer
delimit
promot
region
nt
nt
amplifi
bp
fragment
polymeras
chain
reaction
pcr
amplif
perform
volum
follow
reaction
buffer
dntp
mmol
primer
u
taq
dna
polymeras
genom
dna
ng
touchdown
pcr
perform
model
geneamp
pcr
system
appli
biosystem
foster
citi
ca
follow
condit
one
initi
denatur
minut
cycl
second
second
everi
cycl
second
cycl
second
second
second
follow
one
elong
step
minut
amplifi
product
analys
agaros
gel
electrophoresi
follow
ethidium
bromid
stain
pcr
amplif
perform
use
condit
primer
primer
describ
pcr
product
recov
purifi
sequenc
reaction
perform
use
pcr
primer
nucleotid
sequenc
obtain
use
autom
sequenc
appli
biosystem
sequenc
align
snp
search
inspect
use
dnastar
analysi
program
dnastar
madison
wi
usa
use
nucleic
acid
sequenc
genebank
nation
center
biotechnolog
inform
ncbi
prototyp
sequenc
genbank
test
differ
promot
polymorph
dcsign
gene
possibl
distort
genotyp
allel
frequenc
case
control
chisquar
test
fisher
exact
test
use
compar
genotyp
allel
distribut
case
control
addit
control
confound
factor
uncondit
logist
regress
analysi
conduct
compar
genotyp
frequenc
case
control
adjust
age
sex
level
educ
analys
perform
spss
softwar
window
version
spss
power
calcul
quanto
program
version
use
haplotyp
frequenc
estim
use
acceler
expect
maximis
algorithm
implement
haploview
v
haplotyp
frequenc
occur
exclud
analysi
associ
test
haplotyp
perform
use
chisquar
test
or
calcul
ci
signific
associ
defin
p
statist
test
twotail
studi
includ
total
npc
patient
control
subject
characterist
studi
subject
summaris
tabl
mean
age
standard
deviat
patient
case
male
control
age
subject
male
statist
signific
differ
case
control
respect
frequenc
distribut
age
sex
distribut
unbias
pvalu
signific
associ
level
educ
npc
suscept
current
studi
case
patient
versu
control
subject
illiter
educ
primari
school
p
direct
sequenc
promot
region
dcsign
reveal
occurr
six
variant
ga
ag
ag
ag
ag
gt
tabl
present
detail
inform
six
variant
minor
allel
frequenc
maf
snp
evalu
dcsign
promot
except
ag
maf
gt
maf
loci
fit
hardyweinberg
equilibrium
expect
pvalu
tabl
present
genotyp
allel
frequenc
six
variant
among
cantones
popul
dcsign
ag
subject
carri
mutant
genotyp
ag
mean
snp
ag
heterozyg
allel
gg
mean
snp
ag
g
allel
ci
ci
increas
risk
develop
npc
respect
compar
carri
wild
genotyp
aa
adjust
age
sex
level
educ
genotyp
ag
gg
ci
ci
increas
risk
develop
npc
respect
compar
carri
wild
genotyp
aa
p
trend
furthermor
subject
carri
risk
allel
g
ci
increas
risk
develop
npc
compar
carri
allel
p
addit
subject
possess
mutant
genotyp
ag
gg
higher
risk
develop
npc
ci
ci
respect
compar
carri
wild
genotyp
aa
carri
risk
allel
g
ci
increas
risk
develop
npc
compar
carri
allel
p
adjust
age
sex
level
educ
signific
associ
gg
genotyp
npc
suscept
p
mayb
mainli
due
small
sampl
size
howev
associ
ag
genotyp
npc
suscept
still
signific
p
dcsign
ga
subject
carri
mutant
genotyp
aa
increas
risk
develop
npc
ci
p
compar
carri
wildtyp
genotyp
gg
associ
still
signific
adjust
age
sex
level
educ
ci
p
furthermor
associ
risk
allel
npc
suscept
statist
signific
ci
p
howev
three
snp
signific
differ
case
control
power
calcul
power
three
signific
snp
respect
moreov
perform
analys
haplotyp
level
found
signific
linkag
disequilibrium
among
dcsign
ag
ag
ag
ga
block
construct
four
snp
figur
tabl
show
result
haplotyp
analysi
reveal
aaag
repres
wildtyp
four
common
snp
g
account
haplotyp
associ
protect
npc
ci
p
use
permut
test
run
also
detect
signific
associ
p
haplotyp
npc
phenotyp
addit
gaga
account
haplotyp
associ
npc
risk
ci
p
howev
use
use
permut
test
run
signific
associ
gaga
npc
phenotyp
p
report
distribut
genet
polymorph
dcsign
promot
cantones
popul
reveal
dcsign
gg
aa
significantli
associ
increas
risk
npc
risk
allel
dcsign
g
significantli
associ
npc
suscept
tabl
haplotyp
analysi
reveal
aaag
contain
four
wildtyp
snp
g
associ
significantli
decreas
risk
npc
gaga
significantli
associ
npc
phenotyp
tabl
moreov
found
two
new
variant
cantones
popul
gt
ag
although
maf
low
respect
current
studi
maf
four
common
snp
ag
ag
ag
ga
promot
region
dcsign
cantones
popul
similar
unrel
han
chines
beij
china
hcb
http
wwwncbinlmnihgovprojectssnpsnp
addit
kashima
et
al
found
allel
frequenc
dcsign
sequenc
asian
howev
snp
neither
detect
barreiro
et
al
asian
koizumi
et
al
japanes
individu
equal
snp
detect
individu
cantones
current
studi
indic
dcsign
widespread
asian
two
snp
promot
region
dcsign
gt
gt
present
current
cohort
though
observ
exclus
zimbabwean
popul
allel
distribut
dcsign
gene
differ
wide
popul
differ
ethnic
group
presum
result
select
pressur
exert
preval
pathogen
geograph
distinct
region
npc
rare
popul
around
world
common
china
southeast
asia
could
reflect
snp
frequenc
dcsign
protein
express
surfac
dc
recent
receiv
consider
attent
research
aid
dengu
tuberculosi
ulcer
coliti
previou
studi
indic
dcsign
g
associ
protect
dengu
diseas
thailand
popul
tuberculosi
diseas
subsaharan
africa
individu
may
mainli
due
locat
dcsign
snp
bp
upstream
major
transcript
site
affect
bind
site
modul
dcsign
transcript
activ
howev
barreiro
colleagu
found
g
variant
confer
protect
tuberculosi
eurasian
popul
meriem
benali
et
al
found
associ
dcsign
promot
variat
suscept
tuberculosi
tunisian
patient
contrast
result
may
due
signific
differ
distribut
dcsign
allel
differ
ethnic
popul
differ
popul
genet
background
well
differ
linkag
disequilibrium
ld
pattern
basi
conflict
result
current
studi
observ
associ
dcsign
snp
npc
suscept
cantones
popul
mechan
involv
mutant
dcsign
pathogenesi
npc
remain
unknown
previou
studi
alreadi
demonstr
higher
frequenc
allel
dcsign
individu
infect
hiv
compar
infect
patient
anoth
studi
allel
g
found
associ
rapid
progress
aid
popul
japanes
haemophiliac
current
studi
found
frequenc
dcsign
gg
aa
significantli
higher
npc
patient
compar
healthi
control
one
potenti
mechan
effect
may
involv
differenti
induc
express
dcsign
blood
dc
result
two
polymorph
remain
demonstr
dcsign
locat
close
one
bind
site
transcript
factor
promot
region
dcsign
could
specul
substitut
one
nucleotid
close
site
may
chang
level
express
dcsign
contribut
progress
npc
dcsign
yet
determin
whether
variant
affect
express
dcsign
ebv
import
etiolog
agent
npc
establish
persist
infect
employ
multipl
strategi
evad
host
immun
respons
consist
critic
function
dc
antivir
immun
myriad
virus
known
infect
differ
subset
dc
affect
differenti
surviv
migrat
andor
cell
stimulatori
capac
howev
studi
perform
far
determin
whether
dcsign
ebv
receptor
ebv
observ
infect
dcsign
posit
cell
immatur
dc
monocyt
macrophag
furthermor
li
et
al
show
ebv
infect
inhibit
dc
develop
monocyt
precursor
show
immatur
dc
becom
resist
ebvinduc
apoptosi
still
support
viru
entri
guerreirocacai
ao
et
al
report
ebvinfect
macrophag
could
facilit
dissemin
ebv
within
oral
mucos
epithelium
recent
dcsign
could
serv
put
receptor
secretori
iga
siga
immatur
dc
bind
high
mannos
glycoprotein
siga
protein
report
sixbey
jw
et
al
demonstr
ebvsiga
complex
promot
ebv
infect
epitheli
cell
secretori
componentmedi
iga
transport
hypothes
dcsign
express
immatur
dc
may
recogn
ebvsiga
complex
though
bind
siga
thu
promot
ebv
infect
immatur
dc
link
dcsign
ebv
infect
immatur
dc
need
confirm
studi
way
lab
would
like
point
sampl
size
current
studi
larg
enough
result
need
valid
larger
sampl
despit
limit
current
studi
repres
first
comprehens
genet
associ
studi
examin
relationship
dcsign
promot
genet
variant
npc
risk
casecontrol
studi
suppli
genet
data
dcsign
promot
polymorph
cantones
popul
studi
show
mutant
genotyp
gg
aa
detect
promot
region
dcsign
gene
involv
npc
suscept
studi
necessari
demonstr
role
dcsign
promot
polymorph
function
dcsign
well
effect
ebv
infect
author
declar
compet
interest
design
studi
whj
msz
collect
sampl
experi
whj
qsf
lzc
wsl
yfx
jqd
wll
yxz
perform
data
analysi
yfx
write
manuscript
yfx
whj
msz
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
